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Background: Chronic Pseudomonas aeruginosa colonisation and subsequent exacerbations in patients with cystic fibrosis (CF) require
antimicrobial treatment. But since multiple morphotypes and other Gram-negative bacteria with different antibiotic susceptibilities are often
isolated inside the same sputum sample, bacteriological analysis is difficult.
Methods: To simplify this analysis, we explored a direct sputum antimicrobial susceptibility testing (DSST) method by applying E test directly on
plates inoculated with the sputum. A total of 316 samples collected from CF patients were analysed and compared with standard procedures (SP)
for the identification and antimicrobial susceptibility testing of all Gram-negative bacterial species.
Results: DSST was as efficient as SP to detect P. aeruginosa including the mucoid morphotype in monomicrobial specimen, but was less sensible
to detect all Gram-negative bacteria present in the same sample. It allowed the direct reading of the MIC inhibiting all Gram-negative bacteria.
Agreements between these global MICs with the cumulative antibiotics susceptibility of all Gram-negative bacteria measured by SP were
excellent for tobramycin and imipenem (N96%) and satisfactory for ticarcillin, ceftazidime, aztreonam and ciprofloxacin (90.4% to 94.3%).
In conclusion, the DSST method is an efficient and easy antibiotic susceptibility testing method.
© 2007 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: E test; Overall MIC; Cystic fibrosis1. Introduction
Pseudomonas aeruginosa is the most frequent and important
endobronchial pathogen associated with mortality and morbidity
in patients with cystic fibrosis (CF). Antimicrobial therapy has
made an important contribution to increase the life expectancy of
CF patients. Because of the frequent administration of antibiotics,
multiresistant strains are increasingly discovered within the P.
aeruginosa species. These bacteria with different susceptibility
patterns associated to multiple colonies morphotypes like mucoid⁎ Corresponding author. Laboratoire de Bactériologie - Hygiène, Hôpital
Calmette, Centre Hospitalier Universitaire, Bvd du Pr. Leclercq, 59037 Lille
cedex, France. Tel.: +33 3 20 44 49 44; fax: +33 3 20 44 48 95.
E-mail address: mohusson@chru-lille.fr (M.-O. Husson).
1569-1993/$ - see front matter © 2007 European Cystic Fibrosis Society. Publishe
doi:10.1016/j.jcf.2007.10.002or small colony variants of P. aeruginosa are often isolated in the
same sputum sample. Other Gram-negative bacteria such as
Burkholderia cepacia complex organisms, Stenotrophomonas
maltophilia, or Achromobacter xylosoxidans have also emerged
due to their innate resistance to many antibiotics. We have to
screen all of themand study their susceptibility to antibiotics, even
if the pathogenic significance (ie S. maltophilia) is not fully
clarified for some of them [1–3].
The principal difficulty in the analysis of CF patients sam-
ples is to identify all different morphotypes of P. aeruginosa
and other microorganisms and to study their antimicrobial sus-
ceptibility in view to guide antibiotherapy. This analysis is
currently based on the antibiotic susceptibility determining of
each morphotype of P. aeruginosa and Gram-negative bacterial
isolates. This method is complex, fastidious and time-d by Elsevier B.V. All rights reserved.
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resistant P. aeruginosa clones within a same sputum sample.
The aim of this multicenter study was to assess a new method
for a simple and efficient determination of the antimicrobial
susceptibility of all Gram-negative bacteria. This method is
performed by the application of gradients of antipseudomonal
antibiotics (E test® strips, AB Biodisk, Solna, Sweden) directly
on agar plates inoculated with the sputum. This method, re-
ferred to as direct sputum antimicrobial susceptibility testing
(DSST), provided an overall “MIC” on the Gram-negative flora.
This overall MIC was compared to the cumulative results of
antimicrobial susceptibility performed against each isolates
with standard procedures (SP). Performances of this method
with regard to detection of all pathogens were also analysed.Fig. 1. Cumulative percentage of global MICs (mg/mL) of ticarcillin, ceftaz
inhibiting all Gram-negative bacteria.2. Materials and methods
2.1. Patients and clinical specimens
Three hundred and sixteen sputum samples were included in
this study. They were recovered from 96 adults (mean age:
23.5 years; range: 18–32) and 41 children (mean age: 14 years;
range: 5–18) known to be chronically infected by P. aeruginosa
alone or in association with other microbial species. Many sam-
ples could be collected from the same patient during the study
time. They harboured either the same predominance of pathogens
with the same antibiotics pattern or harboured different patterns of
resistance, bacterial species and different rates of colonisation
since patients received antibiotic treatments during this time. Inidime, imipenem, aztreonam, tobramycin and ciprofloxacin
Table 1
Comparison of antimicrobial susceptibilities measured by DSSTand by standard
procedures (SP) according to each antibiotic
Antibiotic Comparison of the susceptibility results obtained by DSST
and SP
Agreement
(%)
Very major
discordance
(%)
Major
discordance
(%)
Minor
discordance
(%)
Ticarcillin 90.4 3.2 4.8 1.8
Aztreonam 94.3 3.7 2 0
Imipenem 96.3 2.2 0.8 0.7
Ceftazidime 92.3 2.5 2.1 3.1
Ciprofloxacin 91.7 6.6 1.1 0.7
Tobramycin 96.1 1.3 0.7 1.9
Results were interpreted as follows: Agreement: DSST=SP. Very major
discordance: DSST sensitive and SP resistant; major discordance: DSST
resistant and SP sensitive; minor discordance: DSST I and SP resistant or
susceptible or SP intermediate and DSST resistant or susceptible.
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in the second we controlled the evolution of microbial flora.
Bacterial analysis was processed using the same procedures in the
4 Cystic Fibrosis Centre-dependant laboratories.
2.2. Direct sputum antimicrobial susceptibility testing (DSST)
Sputum samples were solubilized in N-acetylcystein (vol/vol),
diluted to 1/20 in saline and swabbed on blood-supplemented
Mueller–Hinton agar plates (BioMérieux, Marcy L'Etoile,
France). E test strips of the following six antibiotics: ticarcillin,
ceftazidime, imipenem, aztreonam, tobramycin and ciprofloxacin,
were placed directly onto different agar plates. The minimal
concentration of the antibiotic that inhibited the totality of Gram-
negative organisms was determined by reading after 18, 24 and
48 h of incubation the antimicrobial concentration printed on the EFig. 2. Cumulative percentage of global MICs (mg/mL) of ticarcillin, ceftaz
inhibiting all Gram-negative bacteria.test strip at its intersection with the growth inhibitory zone of all
Gram-negative isolates according to the recommendations of the
manufacturer. The reading of the global MICs was checked by 2
different persons. Bacterial identification was performed as ex-
pected in all different colonies.
2.3. Standard procedures (SP)
A calibrated aliquot (100 μl) of such solubilized sputum and its
dilution (1/100 in saline water) were set up for quantitative culture
on a panel of non-selective and selective media (BioMérieux,
Marcy L'Etoile, France) including at least Colombia colistin–
nalidixic acid agar (CNA), B. cepacia-selective medium [3] and
cetrimide agar. After 18 to 24 h of incubation, all colonies corre-
sponding to the same bacterial species were counted. Identification
of organisms was performed by means of standard microbiological
tests including API 20 NE strips (bioMérieux, Marcy l'Etoile,
France). If necessary, partial 16SrRNA gene sequencing was used
for the identification of atypical non-fermenting Gram-negative
bacteria. A threshold of 102 CFU/mL for P. aeruginosa and B.
cepacia and of 105 CFU/mL for the other species was considered
significant.
Antimicrobial susceptibility testing was performed on each
morphotype of P. aeruginosa, as well as on other Gram-negative
non-fermenters using the disk diffusion test on Mueller–Hinton
agar (BioMérieux, Marcy L'Etoile, France). The inhibition zone
diameters were measured after 18 to 24 or 48 h of incubation to
accommodate slower-growing strains, and susceptibility inter-
preted using NCCLS criteria now CLSI [4].
2.4. Interpretation of results
The results obtained byDSSTwere compared to the cumulative
susceptibility of all morphotypes of P. aeruginosa and otheridime, imipenem, aztreonam, tobramycin and ciprofloxacin
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an antibiotic when all bacterial strains were susceptible and resis-
tant to an antibiotic onlywhen onemorphotype ofP. aeruginosa or
another Gram-negative bacterial species was resistant. DSST
susceptibility results defined as “observed” susceptibility were
compared to the “predicted” susceptibility inferred from the most
resistant cumulative pattern of all individual P. aeruginosa
morphotypes and other Gram-negative bacteria. Discrepancies
between the “predicted” and “observed” susceptibilities were
classified as very major (VM) if “predicted” resistant, “observed”
susceptible, major (M) if “predicted” susceptible, “observed
resistant”, minor (MN) if “predicted” or “observed” intermediately
susceptible, other results susceptible or resistant.
3. Results
3.1. Microbiology of the sputa
The analysis of the Gram-negative flora by SP showed that P.
aeruginosa was recovered from 303 of the 316 sputa (95.8%).
The bacterial load was≥ to 105 CFU/mL for 276 of them (91%).
Six hundred and fifty-one mucoid or non-mucoid morphotypes,
with different antibiotics susceptibility patterns of P. aeruginosa,
which result in a mean of 2.2 (range 1–4) morphotypes per
specimen, were differentiated. P. aeruginosa was the sole path-
ogen in 241 (79.5%) of sputa and was associated either with S.
aureus in 32 sputa (10.5%) or other Gram-negative bacteria in 30
sputa (10%). A total of 48 strains of non-P. aeruginosa Gram-
negative non-fermentative bacteria have been isolated. They
belonged to the following species: A. xylosoxidans (n=17), B.
cepacia (n=12), S. maltophilia (n=12), Bordetella bronchisep-
tica (n=3), Sphingomonas paucimobilis (n=2), Sphingobacter-
ium multivorum (n=1) and Ochrobactrum anthropi (n=1).Table 2
Comparison of the ability of standard procedures (SP) and DSST to detect
Gram-negative non-fermentative organisms in 316 CF sputa
Composition of the Gram-negative bacteria
from SP
Performance of DSST for the
detection of
Bacterial species P. aeruginosa rate
of colonisation
P. aeruginosa GNFB
P. aeruginosa alone
(n a=241)
b105 CFU/mL
(n=21)
11 (52.4%)
N105 CFU/mL
(n=220)
220/220
(100%)
P. aeruginosa+
S. aureus (n=32)
b105 CFU/mL
(n=3)
2/3
N105 CFU/mL
(n=29)
24/29
(82.7%)
P. aeruginosa+
other GNFB (n=30)
b105 CFU/mL
(n=2)
0/2 2/2
N105 CFU/mL
(n=28)
24/28
(85.7%)
16/28 (57%)
Other GNFB (n=13)
One GNFB
alone (n=8)
One GNFB:
7/8 (87.5%)
Two GNFBs
associated (n=5)
Two GNFBs:
3/5 (60%)
a n=number of sputa.3.2. Accuracy of antimicrobial susceptibility testing
Fig. 1 showed direct E test on sputum sample containing
different morphotypes and susceptibility levels P. aeruginosa.
Minimal concentrations of antibiotic inhibiting the totality of
Gram-negative bacilli was measured by reading after 18, 24 and
48 h of incubation the antimicrobial concentration printed on the
E test strip at its intersection with the growth inhibitory zone of all
Gram-negative bacteria. They were compared to the cumulative
antibiograms performed on each morphotype of P. aeruginosa
and other Gram-negative organism in Table 1. Categorical agree-
ments varied from 90.4% to 96.3% according to the antibiotic.
The best correlations between “predicted” and “observed” sus-
ceptibilities were observed for tobramycin and imipenem
(N96%). On the contrary, the highest rate of VM discrepancies
was observed for ciprofloxacin (6.6%). Finally, the rate of agree-
ment was better for aztreonam (94.3%) and ceftazidime (92.3%)
than for ticarcillin (90.4%).
The distribution of the global minimal concentrations of
antibiotics inhibiting the all Gram-negative bacteria present in
the sputum was summarized in Fig. 2. This distribution demon-
strated a great variability in MICs of antibiotics. Within sus-
ceptible β lactams or tobramycin strains, MICs could vary from
very low values as 0.128 μg/mL to values near the breakpoints
(4 or 8 μg/mL). The same range was observed for resistant
strains with values from 32 mg/L to over 256 μg/mL.
3.3. Accuracy of detection of microorganisms
Performances of DSST to screen P. aeruginosa and the other
Gram-negative bacteria were compared to SP in Table 2. DSST
was as sensitive as SP for the detection of P. aeruginosa when it
was the sole pathogen and present at a rate of colonisation
N105 CFU/mL. This method was also as effective as SP to
recognize the different morphotypes of P. aeruginosa (data not
shown). However, the rate of P. aeruginosa detection by DSST
decreased to 85.7%, when P. aeruginosa was associated with
another Gram-negative organism, to 82.7% when it was asso-
ciated with S. aureus and further more (52.4%) if the rate of
colonisation was low. DSST was as efficient as SP to detect the
non-P. aeruginosa Gram-negative from monomicrobial speci-
men (87.5%), but it failed in this way when many bacterial
species were mixed in the same sample (60%). Nevertheless,
one of the P. aeruginosa and A. xylosoxidans colonisations
was only detected by means of DSST thanks to gradients of
antibiotics.
Finally, the comparison of the performances of the DSST
method did not show any significant inter-laboratory variations
among the 4 participating laboratories (data not shown).
4. Discussion
Selection of the most appropriate antibiotic therapy is essential
for the treatment of bronchial exacerbations in CF patients. Stan-
dard methods of isolating and testing individual colony types from
a sputum are expensive, time-consuming, and they don't ensure the
detection of the most resistant organisms. Two strategies have been
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of antibiotic-containingmedia, allowing the detection of organisms
exhibiting innate or acquired resistance to these antibiotics. Van
Dalfsen et al. [5] demonstrated that a tobramycin-containing medi-
um was more sensitive than the standard detection method for the
detection of tobramycin-resistant P. aeruginosa, S. maltophilia and
A. xylosoxidans strains. Besides, preparation of selective media
with antibiotics such as imipenem or colistin has been proposed to
detect these specific Gram-negative bacterial species from their
antibiotic innate resistance [6]. The second one is to analyse sus-
ceptibility tests on P. aeruginosa using a mixed-morphotype inoc-
ulum. Correlations of these methods performed on mixed strains
with broth microdilution susceptibility or disk diffusion methods
performed on individual morphotypes were of 96 and 92.2%
respectively [7,8].
In the present study, we evaluated a new approach by deter-
mining the global MIC of 6 antipseudomonal compounds on all
Gram-negative bacteria by placing E test strips directly on agar
plates inoculated with sputum. This method is based on the
properties of E test which is an inoculum-tolerant and drug stable
system and allows thus right MICs determination [9]. This
method was assessed by comparing global MIC results with the
cumulative susceptibility of all bacterial strains measured using
the disk diffusion test. Agreement was excellent for tobramycin
and imipenem (N96%) and satisfactory (90.4% to 94.3%) for the
other antibiotics tested. Resistance to ciprofloxacin appeared
however underestimated by DSST in 6.6% of cases. This
discrepancy was due to a majority of borderline strains for which
MICs were near the breakpoints defining resistance or suscept-
ibility. The superiority of DSST over standard procedures with
regard to the detection of resistant strains defining here as M
discordance was demonstrated in 0.7 to 4.8% of cases. We don't
know if the resistant P. aeruginosa clones are potentially more
pathogens than susceptible clones. But this method is more
representative of what is going on in the lung than SP and has
certainly better relevance in clinical outcome. The other
potential advantages of this method were to obtain results
within 48 h rather 3 to 4 days with SP and to provide a simple
microbiological interpretation by reporting only the overall
concentrations of antibiotic inhibiting all Gram-negative
bacteria. This method could help the clinicians for screening
the most efficient antibiotic by comparing MICs or checking
antibiotic resistance by following MICs increase.
DSSTmethod performanceswere also evaluated in regard to its
power to detect P. aeruginosa including mucoid morphotypes and
other non-fermentative bacteria colonisation. DSSTwas proven to
be reliable essentially when P. aeruginosa was the sole pathogen
isolated and when colonisation was heavy (N105 CFU/mL). Co-
colonisation with S. aureus or other multiresistant organisms, such
as S. maltophilia or A. xylosoxidans, which are not clearly asso-
ciatedwith clinical deterioration, might lead to an underestimation
of P. aeruginosa colonisation by covering it when such a global
test on the whole Gram-negative flora was performed. This new
method failed also in the detection of all Gram-negative species
when they were mixed in the same sample. Thus the DSST
method could not serve as substitute for SP to check low
colonisations of the main species B. cepacia and P. aeruginosaand to define the right composition of the flora. For these requests,
we recommend to check the low colonisations of the two main
species by isolating undiluted sputum on selective media for each
sample analysed by DSST and the presence of the other Gram-
negative bacteria by performing alternatively bacteriological anal-
ysis by SP even if they are not clearly associated with clinical
deterioration.
Our method is currently efficient only for Gram-negative
bacteria and cannot be applied to S. aureus for which the antibiotic
susceptibility is different. But, colonies ofS. aureus could be easily
detected on agar plates used for DSST, and we could determine its
antimicrobial susceptibility by a standard susceptibility test.
At the present time, the treatment of P. aeruginosa infection
consists of a combination of 2 or 3 antibiotics. The checkerboard
technique is the usual method to determine synergism. Recently,
many works have reported the use of E test to assess the activity of
antimicrobial combinations by superposing E test strips and com-
paring MICs of antibiotics tested alone in association. Agreement
between the checkerboard method and the E test was 90% for B.
cepacia [10] and superior to 90% for P. aeruginosa strains
includedmucoid isolates from cystic fibrosis patients [11]. The aim
of this current study was to evaluate the accuracy of a direct
susceptibility test on CF sputum using E test, but our results
support the further evaluation of the E test to apply this method
directly on CF sputum.
In conclusion, DSST is an efficient alternative method for
rapidly determining the susceptibility of all Gram-negative bac-
terial species recovered from sputum of CF patients and to
follow their resistance by controlling any increase in theMICs of
antibiotics. It represents a lower cost by limiting manipulations
and the number of antibiotics tested. It improves the interpreta-
tion of the bacteriological sputum analysis and allows the detec-
tion of all resistant bacteria. This request is appropriate for the
main antibiotics and especially for tobramycin in patients re-
ceiving inhaled tobramycin. Further clinical trials should now be
performed to establish whether the use of the DSST method and
its application to antibiotics associations could lead to better
therapeutic results.
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